A subanalysis of the COMPASS trial found that combination treatment with rivaroxaban and aspirin reduced incidence of major adverse limb events by 43%.
Gregory W. Rutecki, MD
A look back at a decade of advances in management of peripheral vascular disease prompted this short summary of big changes.
Severe hypoglycemia was associated with death within ~1 week among patients with T2DM, according to a subanalysis of the LEADER trial.
When CKD 4-5 progresses to ESRD, how should hypertension management be changed? Or, should it?
Hypertension in persons with HIV is a significant CV risk factor and should be a target of focused prevention in primary care.
After stroke and bleeding risk are calculated and anticoagulation commences, hypertension control is essential to prevent CV events.
The author wants your opinion on the habitual titration of β-blockers in patients with comorbid HF who are not at BP goal.
More patients were found to be at blood pressure goal in primary care settings vs specialty practice in a new study. Our author looks at possible reasons why.
Anything less than comprehensive care for type 2 diabetes is quickly becoming old school.
Hypertension is common and dangerous in HIV-infected persons. Primary care plays a vital role in detecting early signs and initiating treatment.